biocon – Heemang Parmar

Uncategorized

Hot Stocks: Brokerage firms on Godrej Consumer, DLF, Zydus Life and Biocon – Heemang Parmar

[ad_1] Brokerage firm Goldman Sachs maintained a buy rating on Godrej Consumer, JPMorgan has an overweight rating on DLF, Axis Capital maintained a buy rating on Zydus Life, and Morgan Stanley retained its overweight stance on Biocon. We have collated a list of recommendations from top brokerage firms from ETNow Read more…

By Heemang, 2 years ago

Uncategorized

Biocon Share Price: Kotak fund invests Rs 1070 crore in Biocon – Heemang Parmar

[ad_1] Kotak Special Situations Fund, managed by Kotak Investment Advisors, on Wednesday announced an investment of Rs 1,070 crore in Biocon. The proceeds will be used to finance Biocon Biologics’ acquisition of the biosimilars business of its partner Viatris to create a global vertically integrated biosimilars player. With the current Read more…

By Heemang, 2 years ago